Adult-onset deletion of β-Catenin in10kb dmp1-expressing cells prevents intermittent PTH-induced bone gain

Rajendra Kedlaya, Kyung Shin Kang, Jung Min Hong, Vidya Bettagere, Kyung Eun Lim, Daniel Horan, Paola Divieti-Pajevic, Alexander Robling

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

β-Catenin (βcat) is a major downstream signaling node in canonical Wingless-related integration site (Wnt) signaling pathway, and its activity is crucial for canonical Wnt signal transduction. Wnt signaling has recently been implicated in the osteo-anabolic response to PTH, a potent calciumregulating factor. We investigated whether βcat is essential for the anabolic action of intermittent PTH by generating male mice with adult-onset deletion of βcat in a subpopulation of bone cells (osteocytes and late-stage osteoblasts), treating them with an anabolic regimen of PTH, and measuring the skeletal responses. Male10kb Dmp1-CreERt2 transgenic mice that also harbored floxed loss-of-function βcat alleles (oβcatf/f ) were induced for Cre activity using tamoxifen, then injected daily with human PTH 1-34 (30 oμg/kg) or vehicle for 5 weeks. Mice in which βcat was deleted showed either total lack of bone mineral density (BMD) gain, or BMD loss, and did not respond to PTH treatment. However, bone mass measurements in the trabecular compartment of the femur and spine revealed PTH-induced bone gain whether βcat was deleted or not. PTH-stimulated increases in periosteal and cancellous bone formation rates were not impaired by βcat deletion, but resorption markers and cortical porosity were significantly increased in induced mice, particularly induced mice treated with PTH. These results suggest that βcat is required for net-positive BMD effects of PTH therapy but that the anabolic effects per se of PTH treatment might not require osteocytic/osteoblasticβcat.

Original languageEnglish (US)
Pages (from-to)3047-3057
Number of pages11
JournalEndocrinology
Volume157
Issue number8
DOIs
StatePublished - Aug 1 2016

Fingerprint

Catenins
Bone and Bones
Bone Density
Anabolic Agents
Osteocytes
Wnt Signaling Pathway
Porosity
Tamoxifen
Osteoblasts
Osteogenesis
Femur
Transgenic Mice
Signal Transduction
Spine
Alleles

ASJC Scopus subject areas

  • Medicine(all)
  • Endocrinology

Cite this

Adult-onset deletion of β-Catenin in10kb dmp1-expressing cells prevents intermittent PTH-induced bone gain. / Kedlaya, Rajendra; Kang, Kyung Shin; Hong, Jung Min; Bettagere, Vidya; Lim, Kyung Eun; Horan, Daniel; Divieti-Pajevic, Paola; Robling, Alexander.

In: Endocrinology, Vol. 157, No. 8, 01.08.2016, p. 3047-3057.

Research output: Contribution to journalArticle

Kedlaya, R, Kang, KS, Hong, JM, Bettagere, V, Lim, KE, Horan, D, Divieti-Pajevic, P & Robling, A 2016, 'Adult-onset deletion of β-Catenin in10kb dmp1-expressing cells prevents intermittent PTH-induced bone gain', Endocrinology, vol. 157, no. 8, pp. 3047-3057. https://doi.org/10.1210/en.2015-1587
Kedlaya, Rajendra ; Kang, Kyung Shin ; Hong, Jung Min ; Bettagere, Vidya ; Lim, Kyung Eun ; Horan, Daniel ; Divieti-Pajevic, Paola ; Robling, Alexander. / Adult-onset deletion of β-Catenin in10kb dmp1-expressing cells prevents intermittent PTH-induced bone gain. In: Endocrinology. 2016 ; Vol. 157, No. 8. pp. 3047-3057.
@article{5a67141071134f2c925ecad3b9d53977,
title = "Adult-onset deletion of β-Catenin in10kb dmp1-expressing cells prevents intermittent PTH-induced bone gain",
abstract = "β-Catenin (βcat) is a major downstream signaling node in canonical Wingless-related integration site (Wnt) signaling pathway, and its activity is crucial for canonical Wnt signal transduction. Wnt signaling has recently been implicated in the osteo-anabolic response to PTH, a potent calciumregulating factor. We investigated whether βcat is essential for the anabolic action of intermittent PTH by generating male mice with adult-onset deletion of βcat in a subpopulation of bone cells (osteocytes and late-stage osteoblasts), treating them with an anabolic regimen of PTH, and measuring the skeletal responses. Male10kb Dmp1-CreERt2 transgenic mice that also harbored floxed loss-of-function βcat alleles (oβcatf/f ) were induced for Cre activity using tamoxifen, then injected daily with human PTH 1-34 (30 oμg/kg) or vehicle for 5 weeks. Mice in which βcat was deleted showed either total lack of bone mineral density (BMD) gain, or BMD loss, and did not respond to PTH treatment. However, bone mass measurements in the trabecular compartment of the femur and spine revealed PTH-induced bone gain whether βcat was deleted or not. PTH-stimulated increases in periosteal and cancellous bone formation rates were not impaired by βcat deletion, but resorption markers and cortical porosity were significantly increased in induced mice, particularly induced mice treated with PTH. These results suggest that βcat is required for net-positive BMD effects of PTH therapy but that the anabolic effects per se of PTH treatment might not require osteocytic/osteoblasticβcat.",
author = "Rajendra Kedlaya and Kang, {Kyung Shin} and Hong, {Jung Min} and Vidya Bettagere and Lim, {Kyung Eun} and Daniel Horan and Paola Divieti-Pajevic and Alexander Robling",
year = "2016",
month = "8",
day = "1",
doi = "10.1210/en.2015-1587",
language = "English (US)",
volume = "157",
pages = "3047--3057",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "8",

}

TY - JOUR

T1 - Adult-onset deletion of β-Catenin in10kb dmp1-expressing cells prevents intermittent PTH-induced bone gain

AU - Kedlaya, Rajendra

AU - Kang, Kyung Shin

AU - Hong, Jung Min

AU - Bettagere, Vidya

AU - Lim, Kyung Eun

AU - Horan, Daniel

AU - Divieti-Pajevic, Paola

AU - Robling, Alexander

PY - 2016/8/1

Y1 - 2016/8/1

N2 - β-Catenin (βcat) is a major downstream signaling node in canonical Wingless-related integration site (Wnt) signaling pathway, and its activity is crucial for canonical Wnt signal transduction. Wnt signaling has recently been implicated in the osteo-anabolic response to PTH, a potent calciumregulating factor. We investigated whether βcat is essential for the anabolic action of intermittent PTH by generating male mice with adult-onset deletion of βcat in a subpopulation of bone cells (osteocytes and late-stage osteoblasts), treating them with an anabolic regimen of PTH, and measuring the skeletal responses. Male10kb Dmp1-CreERt2 transgenic mice that also harbored floxed loss-of-function βcat alleles (oβcatf/f ) were induced for Cre activity using tamoxifen, then injected daily with human PTH 1-34 (30 oμg/kg) or vehicle for 5 weeks. Mice in which βcat was deleted showed either total lack of bone mineral density (BMD) gain, or BMD loss, and did not respond to PTH treatment. However, bone mass measurements in the trabecular compartment of the femur and spine revealed PTH-induced bone gain whether βcat was deleted or not. PTH-stimulated increases in periosteal and cancellous bone formation rates were not impaired by βcat deletion, but resorption markers and cortical porosity were significantly increased in induced mice, particularly induced mice treated with PTH. These results suggest that βcat is required for net-positive BMD effects of PTH therapy but that the anabolic effects per se of PTH treatment might not require osteocytic/osteoblasticβcat.

AB - β-Catenin (βcat) is a major downstream signaling node in canonical Wingless-related integration site (Wnt) signaling pathway, and its activity is crucial for canonical Wnt signal transduction. Wnt signaling has recently been implicated in the osteo-anabolic response to PTH, a potent calciumregulating factor. We investigated whether βcat is essential for the anabolic action of intermittent PTH by generating male mice with adult-onset deletion of βcat in a subpopulation of bone cells (osteocytes and late-stage osteoblasts), treating them with an anabolic regimen of PTH, and measuring the skeletal responses. Male10kb Dmp1-CreERt2 transgenic mice that also harbored floxed loss-of-function βcat alleles (oβcatf/f ) were induced for Cre activity using tamoxifen, then injected daily with human PTH 1-34 (30 oμg/kg) or vehicle for 5 weeks. Mice in which βcat was deleted showed either total lack of bone mineral density (BMD) gain, or BMD loss, and did not respond to PTH treatment. However, bone mass measurements in the trabecular compartment of the femur and spine revealed PTH-induced bone gain whether βcat was deleted or not. PTH-stimulated increases in periosteal and cancellous bone formation rates were not impaired by βcat deletion, but resorption markers and cortical porosity were significantly increased in induced mice, particularly induced mice treated with PTH. These results suggest that βcat is required for net-positive BMD effects of PTH therapy but that the anabolic effects per se of PTH treatment might not require osteocytic/osteoblasticβcat.

UR - http://www.scopus.com/inward/record.url?scp=84982841170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982841170&partnerID=8YFLogxK

U2 - 10.1210/en.2015-1587

DO - 10.1210/en.2015-1587

M3 - Article

VL - 157

SP - 3047

EP - 3057

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 8

ER -